Director Carla Ji-Eun Kim will be speaking on the panel “The latest developments in patent prosecution and exclusivity extension” at the MIP Life Sciences Forum 2019 in New York, NY on September 18, 2019.

Panel Overview:

  • Subject matter eligibility in life sciences – what you need to know
  • Comprehending how Humira has been able to extend market exclusivity on some uses until 2034
  • What are the latest patent prosecution strategies for biosimilars?
  • What are the precise mechanics of bringing a biosimilar to market?
  • China update – the latest on patent law reform

Related Professionals

Related Services